Lymphoma Large B-Cell Diffuse
Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma: an analysis of two LYSA studies
... Abstract CNS relapse is reported in 2–5% of diffuse large B- cell lymphoma (DLBCL) patients, dramatically decreasing overall survival (OS). Very few studies address incidence and risk ...
10
CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma
... novo diffuse large B-cell lymphoma; DLBCL(t): diffuse large B-cell lymphoma trans- formed; TCR: T-cell rich B-cell ...
9
Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
... in diffuse-large B-cell lymphoma (DLBCL) compared to another type of mature aggressive B-cell lymphoma, Burkitt ...
13
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.
... with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study ...in diffuse large B-cell lymphomas treated within randomized trials of the German ...
12
Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044
... Abstract Diffuse large B- cell lymphoma (DLBCL) is the most common form of non- Hodgkin’s ...DLBCL cell lines with SM1044 induces autophagy- dependent apoptosis, which is ...
18
Role of ETS1 in the transcriptional network of diffuse large B cell lymphoma of the activated B cell-like type
... Abstract: Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease that has been distinguished into at least two major molecular entities, the germinal center-like B ...
17
Subcutaneous Rituximab-MiniCHOP compared with subcutaneous Rituximab-MiniCHOP plus Lenalidomide in diffuse large B-Cell lymphoma for patients age 80 years or older.
... with diffuse large B-cell lymphoma (DLBCL) is worse than that of young ...center B-cell–like phenotype. The Lymphoma Study association conducted a multicentric, ...
12
Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies
... ABSTRACT Primary bone diffuse large B-cell lymphoma (PB-DLBCL) is a rare DLBCL location variant. We treated 76 PB-DLBCL patients by immuno-chemotherapy, resulting in an 84% sustained ...
8
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients
... with diffuse large B cell lymphoma ...T cell technology has fuelled demand for validated cancer ...T cell (CTL) and a CD4 T-helper (Th) ...
10
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort
... of diffuse large B-cell lymphoma (DLBCL) © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution ...
14
Cytolytic T-cell response to the PASD1 cancer testis antigenin patients with diffuse large B-cell lymphoma
... with diffuse large B-cell lymphoma Diffuse large B-cell lymphoma (DLBCL), representing 40% of non-Hodgkin lymphoma (NHL), is heterogeneous with ...
12
Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma.
... www.landesbioscience.com Cell Cycle 1811 Cell Cycle 12:12, 1811–1812; June 15, 2013; © 2013 Landes Bioscience EditoriaLs: CELL CyCLE FEaturEs EditoriaLs: CELL CyCLE FEaturEs Diffuse ...
3
Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients
... 6 Drake MT, Maurer MJ, Link BK, Habermann TM, Ansell SM, Micallef IN et al. Vitamin D Insufficiency and Prognosis in Non-Hodgkin’s Lymphoma. J Clin Oncol 2010; 28: 4191–4198. 7 Wilcox RA, Ristow K, Habermann TM, ...
12
Gene expression-based risk score in diffuse large B-cell lymphoma.
... develop lymphoma after a long latency[33]. In non-Hodgkin lymphoma, MCL1 expression was signiicantly lower in patients in complete remission than with progressive ...
12
A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival
... Clinical characteristics At diagnosis were collected: age (coded in tertile in our models), gender, the presence or absence of systemic (B) symptoms; the Ann Arbor stage (localized (Ann Arbor stage I or II) or ...
12
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
... Two other genes (APOBEC3G, RAB33A) showed differential effects in CHOP and R- CHOP patients and demonstrated a significant correlation with OS in R-CHOP patients independently of the COO classification. APOBEC3G encodes ...
23
An alternative way to look at diffuse large B-cell lymphoma : the impact of frequent engagement of ReIB NF-κB subunit on cell survival and patient outcome
... dendritic cell function, and secondary lymphoid tissue organization [ 25 – 28 ], indicating that RelB exerts a crucial positive effect for these developmental processes that cannot be compensated for by the ...
138
Diffuse large B-cell lymphoma of Waldeyer's ring has distinc clinicopathologic features: a GELA study.
... WR DLBCLs frequently exhibit a partially nodular growth pattern Although all cases ful filled the DLBCL diagnostic criteria and the majority of the cases (144 cases, 77%) exhibited a purely diffuse distribution of ...
9
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study.
... immunohistochemistry Immunohistochemistry was carried out using an indirect immunoperoxidase method. The following markers were used after appropriate antigen retrieval: BCL2, CD20, CD44, CNA.42, HLADR, MUM-1/IRF4 ...
9
Long non-coding RNAs as molecular signatures for canine B-Cell lymphoma characterization
... Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in ...
12